CBT-I works for '70% of patients' — the Headspace Sleep Advisor on therapy for insomnia
When you buy through links on our articles, Future and its syndication partners may earn a commission.
According to the American Academy of Sleep Medicine, 12% of US adults are diagnosed with chronic insomnia, a disorder that makes falling asleep and staying asleep difficult.
While treatment for insomnia can include medication, more and more people are turning to CBT-I (Cognitive Behavioral Therapy for Insomnia). This form of therapy is designed to address the root factors contributing to insomnia, rather than just medicating symptoms.
But how effective is it? We spoke to Dr Aric Prather, Sleep Advisor to wellness app Headspace, and the Director of the Behavioral Sleep Medicine Research Program at the University of California at San Francisco, to find out more following the launch of Headspace's new CBT-I sleep programme Finding Your Best Sleep. Here's what he told us...
"Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold-standard empirically supported treatment for insomnia, and should be the first line treatment for individuals with insomnia before embarking on pharmacologic treatment," says Dr Aric.
CBT-I also addresses the anxiety that develops with unpredictable sleep
"Unlike hypnotic medication, CBT-I addresses the perpetuating factors that drive insomnia, and provides the patient with science-backed strategies to improve sleep by consolidating sleep and entraining their circadian rhythm.
"CBT-I also addresses the anxiety that develops with unpredictable sleep by incorporating relaxation techniques and psychological strategies like cognitive restructuring.
"The goal is to help patients better regulate their sleep, find some success in sleeping, and build confidence and resilience."
"CBT-I focuses specifically on sleep and insomnia symptoms. Unlike other CBT therapies, CBT-I is heavily behavioral. We know quite a bit about what regulates our sleep biologically, so that's where we start.
"Focusing on standardizing someone's wake up time, implementing stimulus control to reduce cognitive arousal in bed, and tracking sleep behavior via a sleep diary followed by restricting their time in bed to increase sleep consolidation can go a long way towards increasing the predictability at nighttime and reducing anxiety prior to and during the night."
"CBT-I can certainly improve anxiety symptoms. In fact, several clinical trials demonstrate that individuals randomized to CBT-I show significant reductions in anxiety symptoms compared to those randomized to control conditions.
"This isn't surprising given that poor sleep often leaves people more 'on edge' and anxious. Headspace also offers a guided program specifically for anxiety and depression, the CBT for Anxiety & Depression program, which incorporates CBT techniques specific to improving anxiety and depression symptoms.
"The course has been shown to decrease anxiety & depression symptoms, improve sleep quality and positively impact mental health and wellbeing (results currently being prepared for peer review)."
"Some people tend to benefit more from CBT-I than others, though much more research is needed to clarify these differences.
There is little downside [to CBT-I], and it's likely to provide you with a greater sense of control over your sleep
"There is some evidence that shorter sleepers with insomnia- those sleeping less than six hours, for example- may struggle with CBT-I more than longer sleepers.
"This is likely because one of the active mechanisms for why CBT-I is effective is through time in bed restriction, which may not be as powerful in those already getting little sleep.
"In my clinical experience, CBT-I may also be less effective in individuals with complex psychiatric or medical presentations.
"In some cases there may be conditions or medications that are impacting sleep where CBT-I may not completely resolve the sleep concern."
"While CBT-I remains the gold standard for treating insomnia, it isn't always accessible. Headspace's sleep course 'Finding Your Best Sleep' was created to expand low-cost access to effective sleep support.
Unlike sleep medications, CBT-I does not carry any long term risk
"The course expands access to proven sleep support by offering expert-led, self-guided sessions that can be completed anytime, anywhere. Included with a Headspace membership, it offers flexibility and affordability—removing common barriers to care.
"The course has been clinically proven to improve insomnia after practicing just 10 minutes a day over the course of 18 days.
"I hope that anyone who is struggling with insomnia will consider a trial of CBT-I in any way that is accessible to them. There is little downside, and is likely to provide you with a greater sense of control over your sleep experience.
"Unlike sleep medications, CBT-I does not carry any long term risk. Moreover, the strategies learned through CBT-I can be useful well into the future and sleep changes as our lives unfold."
"My suspicion is that stress and feelings of uncertainty are the most likely culprits of insomnia. For so many- too many- we feel like we are in a state of hypervigilance, and this results in nights of disturbed sleep.
In turn, we often lack the emotional resources to deal with the stressors the following day, leading to yet another night of poor sleep.
Thankfully, programs like CBT-I can help provide a roadmap to better regulate our sleep, and when coupled with stress management strategies, can help us cope with this stressful world."
"First, I would say that they are not alone. In fact at least 30% of adults, if not more, are not getting adequate sleep. The second piece of advice is to take stock of your sleep life. Is it that you are getting sleep but don't feel refreshed?
At least 30% of adults, if not more, are not getting adequate sleep
"Is something disrupting your sleep? Are you so pressed for time that you are not giving yourself enough opportunity? The answer to these questions will lead to different solutions.
"If you are worried about your sleep, the first step could be to talk to your doctor to make sure that you don't have a sleep disorder, like sleep apnea, disrupting your sleep.
"If not and you're looking for a personalised approach, consider trying CBT-I through a sleep specialist, I always suggest that people explore the Society for Behavioral Sleep Medicine directory to find someone in their region."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
Just 1 dose of magic mushroom compound eases depression for at least 5 years in most patients, small study suggests
When you buy through links on our articles, Future and its syndication partners may earn a commission. DENVER—Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a single dose, a new study finds. The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, focused on patients with major depressive disorder (MDD), which is often called clinical depression. The serious mood disorder causes a persistent feeling of sadness and a loss of interest or pleasure in activities that were once enjoyable. The most common treatments for MDD include talk therapy and medications such as selective serotonin reuptake inhibitors, and both can take a long time to show any benefits. When early studies hinted at psilocybin's potential as an antidepressant, a team of researchers undertook the first-ever randomized clinical trial to explore the use of the psychedelic for treating severe depression. The trial included 24 patients, half of whom received psilocybin at the very start of the trial and half of whom received the same dose eight weeks later—the "waitlist" group. Each patient also received 11 hours of psychotherapy. Even in that short time frame, "there was a significant reduction in depression in the immediate-treatment group compared to those on the waitlist," study co-author Alan Davis, director of the Center for Psychedelic Drug Research and Education at The Ohio State University, told Live Science. Once all of the patients had completed the four-week study, the psilocybin appeared to be four times more effective than traditional antidepressant medications, based on previous research data. One month after the treatment, 17 patients had relieved symptoms, including 14 who were in full remission from depression. Patients also responded much faster to psilocybin than is typical for conventional antidepressants. But do these benefits of psilocybin last? Related: Magic mushrooms temporarily 'dissolve' brain network responsible for sense of self Very few long-term studies of psilocybin for depression have been conducted to date, said Dr. Charles Raison, a professor of human ecology and psychiatry at the University of Wisconsin-Madison who was not involved in the research. "They are very difficult to do because people drop out," Raison told Live Science in an email. "But also because they go on all sorts of other treatments that obfuscate the degree to which any longer lasting benefits result from the psychedelic or because the participant got therapy or restarted an antidepressant." To investigate whether the benefits for psilocybin lasted and if the patients had experienced any side effects, the researchers contacted the original trial participants several years later to request their enrollment in a follow-up study. Twenty-one patients enrolled, and their clinicians rated any changes in the participants' levels of depression from before the original treatment to the present day. The patients also filled out a series of self-reported, online questionnaires and met up with clinicians to document their ability to engage in everyday tasks, their levels of anxiety and their general mental health. The researchers assumed that the three patients that didn't sign up for the follow up, and the three that didn't complete the questionnaires had not remained in remission. Even so, the researchers found that 67% of the participants who had suffered from depression half a decade earlier remained in remission after a single psychedelic therapy session. These patients also reported less anxiety and less difficulty functioning on a daily basis. In general, the two-thirds of the patients who responded well reported lasting positive changes in their mindsets, emotional health and relationships. "I'm excited by these deeper aspects of their lives that really speaks to the importance of these interventions beyond just reduction of depression," Davis said. RELATED STORIES —Psychedelics rapidly change the brain. Here's how. —Australia clears legal use of MDMA and psilocybin to treat PTSD and depression —'Magic mushroom' treatment for depression inches closer to approval Most of the patients shared that, following the original treatment, they'd engaged in self-reflection and therapy to help understand themselves and navigate life's challenges. Davis hypothesizes that the psychedelic experience catalyzes a deeper therapy process and would like to conduct future studies comparing the relative influences of psilocybin and psychotherapy in alleviating depression. "The biggest caveat of this study is the small sample size, and the fact that the original trial showed larger antidepressant effects than subsequent larger multi-site studies seem to be showing," Raison said. In a multi-site clinical trial with 233 participants, 37% of the 79 who received a single 25 mg dose of psilocybin, coupled with psychotherapy, went into remission from major depression. While these trials report less widespread antidepressant effects, they support the idea that psilocybin can effectively treat depression, Davis said, and he is keen to see how the findings of multi-site trials hold up five years post-treatment.
Yahoo
12 hours ago
- Yahoo
Science news this week: 'Dragon Man's' identity and the universe's 'missing matter'
When you buy through links on our articles, Future and its syndication partners may earn a commission. This week's science news reveals the identity of the mysterious "Dragon Man," while also finding clues to the universe's "missing matter." In 1933, a Chinese laborer in Harbin City discovered a human-like skull with a huge cranium, broad nose and big eyes. Just under 90 years later, experts gave this curious specimen a new species name — Homo longi, or "Dragon Man" — due to its unusual shape and size. But this classification has not gone unchallenged, with many scientists saying this skull belongs not to a new species, but instead to an ancient group of humans called Denisovans. Now, a pair of new studies claim to have finally put the mystery to bed. Another mystery that we came one step closer to solving this week is where the universe's "missing" matter is hiding. Ordinary or "baryonic" aryonic matter, which is composed of particles like protons and neutrons, makes up just 5% of the universe, but scientists have been able to observe only about half as much of it as they expected. To find the missing matter, researchers search for clues by studying short, extragalactic flashes known as fast radio bursts, which light up the intergalactic space that lies between them and Earth — and they may have just found some. Although very few long-term studies of psilocybin — the main psychoactive ingredient in magic mushrooms — as a treatment for depression have been conducted to date, new research presented this week at the Psychedelic Science 2025 conference suggests it can alleviate depression for at least five years after a single dose. The researchers found that 67% of study participants who had suffered from depression half a decade earlier remained in remission after a single psychedelic therapy session, while also reporting less anxiety and less difficulty functioning on a daily basis. Discover more health news —Iron deficiency in pregnancy can cause 'male' mice to develop female organs —The brain might have a hidden 'off switch' for binge drinking —Ketamine may treat depression by 'flattening the brain's hierarchies,' small study suggests The world is awash with the color purple — lavender flowers, amethyst gemstones, plums, eggplants and purple emperor butterflies. But if you look closely at the visible-light portion of the electromagnetic spectrum, you'll notice that purple is absent. So does that mean the color doesn't really exist? Not necessarily. —If you enjoyed this, sign up for our Life's Little Mysteries newsletter Asking artificial intelligence reasoning models questions on topics like algebra or philosophy caused carbon dioxide emissions to spike significantly. Specialized large language models (LLMs), such as Anthropic's Claude, OpenAI's o3 and DeepSeek's R1, dedicate more time and computing power to producing more accurate responses than their predecessors, but a new study finds the cost could come at up to 50 times more carbon emissions than their more basic equivalents. While the study's findings aren't definitive — emissions may vary depending on the hardware used and the energy grids used to supply their power — the researchers hope their work should prompt AI users to think before deploying the more advanced technology. Read more planet technology news —This EV battery fully recharges in just 18 seconds — and it just got the green light for mass production —Hurricanes and sandstorms can be forecast 5,000 times faster thanks to new Microsoft AI model —China pits rival humanoids against each other in world's first 'robot boxing tournament' —14,000-year-old ice age 'puppies' were actually wolf sisters that dined on woolly rhino for last meal —Nobel laureate raises questions about AI-generated image of black hole spinning at the heart of our galaxy —Enslaved Africans led a decade-long rebellion 1,200 years ago in Iraq, new evidence suggests —Covering poop lagoons with a tarp could cut 80% of methane emissions from dairy farms —Satellite coated in ultra-dark 'Vantablack' paint will launch into space next year to help combat major issue The Colorado River snakes through seven U.S. and two Mexican states, and supplies some 40 million people, including those in Phoenix and Las Vegas, with their water needs. But as supplies of this surface water reach record lows, more and more people have been pumping groundwater from far below the surface. Stark new satellite data reveal that the Colorado River basin has lost huge amounts of groundwater over the last few decades, with some research suggesting that this groundwater could run out by the end of the century. But is that really the case? And if so, what could be done to prevent that happening? —How to see the groundbreaking space photos from the world's largest camera [Astronomy] —Instead of 'de-extincting' dire wolves, scientists should use gene editing to protect living, endangered species [Opinion] —Crows: Facts about the clever birds that live all over the world [Fact file] —Best thermal binoculars: Observe nocturnal wildlife after dark [Buying guide] —Watch David Attenborough's 'Ocean' from anywhere in the world with this NordVPN deal — and grab an Amazon voucher just in time for Prime Day [Deal] A massive eruption at Indonesia's Mount Lewotobi Laki-laki volcano sent giant plumes of ash spewing more than 6 miles (10 kilometers) into the skies on Tuesday (June 17), followed by a second eruption just a day later. This incredible mushroom-shaped cloud could be seen over 95 miles (150 km) away, and was accompanied by rumbling, lightning and thunder, typical of explosive eruptions that spew enormous amounts of material — much of which showered over nearby villages. Warning signs at Lewoboti Laki-laki prompted officials to raise the eruption alert to the highest level on Tuesday, according to a statement, and fortunately at time of writing there have been no reports of casualties. Want more science news? Follow our Live Science WhatsApp Channel for the latest discoveries as they happen. It's the best way to get our expert reporting on the go, but if you don't use WhatsApp we're also on Facebook, X (formerly Twitter), Flipboard, Instagram, TikTok, Bluesky and LinkedIn.
New York Post
a day ago
- New York Post
Kate Middleton shares a a heartfelt statement after pulling out of Royal Ascot
Kate Middleton revealed why she was absent from Royal Ascot. The Princess of Wales, 43, was expected to attend the annual horse race on Tuesday and Wednesday alongside Prince William, King Charles, Queen Camilla and other royal family members. However, Middleton ended up pulling out and is now addressing how she spent the last few days. In a Friday message, Middleton showed her support during Children's Hospice Week, highlighting the work she has been busy doing. 4 Kate Middleton reveals what she's been focused on the past week. 'No parent expects to hear that their child has a serious health condition that could shorten their life,' the Princess wrote. 'Sadly, this is the reality faced by thousands of families across the country, leaving them heartbroken, fearful of the future and often desperately isolated.' 'Being able to access the support of one of the U.K.'s 54 children's hospices means they don't have to face that future alone,' added Middleton. 'As Patron of East Anglia's Children's Hospices and Tŷ Hafan Children's Hospice in South Wales, I have the immense privilege of seeing for myself the extraordinary work of our children's hospices,' she continued. 'Lifting spirits through laughter, fun and play, as well as listening, holding, caring and sharing, they support children and families through life, death and beyond.' 4 Catherine, Princess of Wales paints the hand of Maggie aged 4 years old whose sibling is being treated at Tŷ Hafan, a children's hospice based in Sully. Getty Images Middleton concluded her message with a note to the public, explaining: 'This Children's Hospice Week,I hope you will join me in celebrating the life-changing work they do and thanking them for the vital care they provide to children and families experiencing the most challenging times.' The Princess has been a stark advocate for kids hospice services since tying the knot with Prince William in 2011. Throughout her overseas tours, Middleton has also visited numerous hospices. In January, the royal visited Tŷ Hafan for the first time in Sully, South Wales, which was built with the support of Princess Diana. 4 Catherine, Duchess of Cambridge visits Waikato Hospice Rainbow Place on April 12, 2014 in Cambridge, New Zealand. Getty Images The director of family well-being services, Tracy Jones, said of the Princess' arrival: 'She immediately gravitated to the children and families — she spent quality time talking to every child and their parents.' 'It's been the most inspiring visit,' Jones continued. 'She crouched down and was straightaway on the level of the children. If they were in a wheelchair, she crouched at that level. If they were on the floor, she would be at the level,' she continues. 'We were seriously impressed with how she could stay in a crouch, as it's not that comfortable!' 4 Prince William, Prince of Wales (Colonel of the Welsh Guards), Prince Louis of Wales, Prince George of Wales, Catherine, Princess of Wales and Princess Charlotte of Wales watch an RAF flypast from the balcony of Buckingham Palace after attending Trooping The Colour 2025 on June 14, 2025 in London, England. Getty Images 'She instinctively seemed to know where to touch a child that was going to provide the connection, but not cause any distress or startle a child. She was looking at the children, even if she was talking to the parent. It's what we do, as we're used to working with children who are nonverbal.' Despite missing out on Royal Ascot, Middleton joined her husband and their three kids Prince George, 11, Princess Charlotte, 10, and Prince Louis, 7, for the annual Trooping the Colour in London on Saturday.
